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Background: Macrophages have many functions in development and homeostasis as well as innate immunity.
Recent studies in mammals suggest that cells arising in the yolk sac give rise to self-renewing macrophage
populations that persist in adult tissues. Macrophage proliferation and differentiation is controlled by macrophage
colony-stimulating factor (CSF1) and interleukin 34 (IL34), both agonists of the CSF1 receptor (CSF1R). In the current
manuscript we describe the origin, function and regulation of macrophages, and the role of CSF1R signaling during
embryonic development, using the chick as a model.
Results: Based upon RNA-sequencing comparison to bone marrow-derived macrophages grown in CSF1, we show
that embryonic macrophages contribute around 2% of the total embryo RNA in day 7 chick embryos, and have
similar gene expression profiles to bone marrow-derived macrophages. To explore the origins of embryonic and
adult macrophages, we injected Hamburger-Hamilton stage 16 to 17 chick embryos with either yolk sac-derived blood
cells, or bone marrow cells from EGFP+ donors. In both cases, the transferred cells gave rise to large numbers of
EGFP+ tissue macrophages in the embryo. In the case of the yolk sac, these cells were not retained in hatched
birds. Conversely, bone marrow EGFP+ cells gave rise to tissue macrophages in all organs of adult birds, and
regenerated CSF1-responsive marrow macrophage progenitors. Surprisingly, they did not contribute to any other
hematopoietic lineage. To explore the role of CSF1 further, we injected embryonic or hatchling CSF1R-reporter
transgenic birds with a novel chicken CSF1-Fc conjugate. In both cases, the treatment produced a large increase in
macrophage numbers in all tissues examined. There were no apparent adverse effects of chicken CSF1-Fc on
embryonic or post-hatch development, but there was an unexpected increase in bone density in the treated
hatchlings.
Conclusions: The data indicate that the yolk sac is not the major source of macrophages in adult birds, and that
there is a macrophage-restricted, self-renewing progenitor cell in bone marrow. CSF1R is demonstrated to be
limiting for macrophage development during development in ovo and post-hatch. The chicken provides a novel
and tractable model to study the development of the mononuclear phagocyte system and CSF1R signaling.
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Figure 1 Comparison of gene expression of chicken bone
marrow-derived macrophages, DF1 fibroblasts and day 7
embryo based upon RNA sequencing. RNAseq of RNA from the
four sources (including two independent biological replicates of
BMDM) was carried out and results analyzed as described in Methods.
This Venn diagram shows the relationship between the datasets. The
numbers represent the numbers of unique gene annotations detected
in each RNAseq library based upon a 1 tag per million threshold.
BMDM, bone marrow-derived macrophages.
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The mononuclear phagocyte system is a family of cells
consisting of committed progenitors, circulating mono-
cytes and tissue macrophages [1,2]. The prevailing view
that blood monocytes give rise to tissue macrophages in
the steady state has been challenged by recent evidence
in the mouse that phagocytic cells arising in the yolk sac
can populate tissues during development and can be
maintained through local proliferation [2,3]. The gener-
ation of phagocytes in the yolk sac and their infiltration
of the embryo has been demonstrated in the chick [4,5]
and in the mouse ([1-3,6-8] and references therein). Yolk
sac-derived macrophages in the chick were shown to
enter the developing central nervous system independ-
ently of vascularization [4]. Their origin was confirmed
through the use of chick-quail yolk sac chimeras [5].
However, the inter-specific chimera system used did not
permit full development, so there was no evidence from
the chick system as to whether the yolk sac-derived cells
were retained post-hatch.
The hematopoietic growth factors macrophage colony-
stimulating factor (CSF1) and interleukin 34 (IL34)
control the proliferation, differentiation and develop-
ment of mammalian mononuclear phagocytes [9,10],
acting through a common receptor, CSF1R. All three
molecules are conserved in birds [11]. A critical control
element in the first intron of the Csf1r locus, termed the
fms intronic regulatory element (FIRE) in mammals [12]
is also conserved in birds [11]. Csf1r mRNA is detected
in the earliest phagocytes in the mouse yolk sac [12,13].
The extreme macrophage deficiency and developmental
abnormalities seen in a Csf1r -/- mouse embryo [14,15]
suggest that CSF1 and IL34 control embryonic macro-
phage differentiation and, in turn, that these cells are re-
quired for normal development.
The contribution of cells that originate in the yolk sac
to tissue macrophage populations has been assessed in
mice through the use of inducible lineage tracers, and
the impact of the knockout of the transcription factor, c-
myb [2,3,13,16,17]. However, such studies depend upon
the assumption that knockouts and inducers such as
tamoxifen do not themselves alter the contribution of
the yolk sac by compromising definitive hematopoiesis
[3]. The chick has been used extensively in developmen-
tal biology because of the ease with which cells and
tissues can be physically transplanted to allow fate-
mapping, an approach made even more straightforward
by our development of ubiquitous enhanced green fluor-
escent protein (EGFP)-expressing chicken lines [18,19].
In the current study we examine the origins of tissue
macrophages during embryonic development and the
importance of CSF1 in the control of macrophage prolif-
eration and differentiation in the chicken. The results
confirm that CSF1 is a regulator of the chick mononuclearphagocyte system in vivo. They also suggest that yolk sac-
derived macrophages in the chick are relatively short-lived
and are substituted by bone marrow-derived macrophages
(BMDM) during development.
Results
Comparative RNA-sequencing analysis of CSF1-stimulated
bone marrow-derived macrophages and embryonic RNA
Macrophages are a major cell population in the develop-
ing mouse embryo, as evident from both in situ
hybridization of Csf1r and other macrophage-related
mRNAs [6], and the location of a macrophage-specific
Csf1r-EGFP reporter transgene [12]. The visualization of
cells expressing CSF1R reporter genes ([20,21] and see
below) in the chick suggests that embryonic macro-
phages are just as abundant in this species, but there is
limited information on macrophage-restricted mRNAs
to enable their characterization.
To reveal macrophage-enriched transcripts, we used
RNA-sequencing (RNAseq) to compare the mRNA pro-
files of BMDM grown in CSF1 with a pool of E7 em-
bryos. The fibroblast line DF1 was used as a negative
control. We identified transcripts with unique annota-
tions, and with an expression threshold of 1 tag/million
(tpm) in the embryo, and created a Venn diagram of
overlapping expression (Figure 1). Around 75% of tran-
scripts detected at 1 tpm were represented in all of the
libraries. At this threshold, 30% to 40% of transcripts
were detected in only one of the two BMDM libraries.
We focused on two sets: 997 transcripts that were
detected in both BMDM libraries and embryo but not in
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libraries (Additional file 1: Tables S1, S2 and S3). The
tables show the relative expression in DF1 cells and em-
bryo compared with BMDM. CSF1R mRNA was detected
in embryos at around 2% of the level found in pure
BMDM. Assuming similar levels of expression of CSF1R
mRNA in tissue macrophages and BMDM, this would
suggest that macrophages contribute around 2% of the
total mRNA, which is consistent with their apparent
abundance. The macrophage-specific transcription factor
PU.1 (SFPI1) had a similar relative enrichment to CSF1R,
whilst several other myeloid transcription factors (MAFB,
CEBPE, TFEC, RUNX1) were less enriched in the BMDM
relative to the embryo, most probably because they are
expressed in other hemopoietic cells (Additional file 1:
Table S1). The macrophage-enriched list also includes
many known macrophage-expressed surface proteins, in-
cluding CSF2RB,CCR2,TREM2,CD36,MRC1, P2RY2, STAB1
and TLR7, detected by network analysis of large mouse,
pig and human datasets [22-24]. The 99 macrophage-
expressed genes that were below the 1 tpm in embryo
are, in fact, detectable. As shown in Additional file 1:
Table S3, they were all highly enriched in BMDM rela-
tive to DF1 cells, and include many genes that are
macrophage-enriched in mice (for example, LY86, CTSS,
C1Q, CSF3R).
The origins of embryonic macrophages
Embryonic macrophages are first observed in the yolk
sac at Hamburger-Hamilton stage (HH) 13, prior to the
first appearance of progenitors of chicken definitive
hematopoietic stem cells in the ventral floor of the dor-
sal aorta around HH16 [25,26]. Recognizable blood
islands containing Runx1+ hematopoietic progenitors
have been detected in HH5 embryos but the cells ex-
pressing a CSF1R-reporter gene appeared in the yolk sac
at HH13. These cells were confined to the lumen of
primitive blood vessels and their numbers rapidly esca-
lated in the circulation [21]. The pattern of emergence is
consistent with previous reports of the earliest appear-
ance of macrophages in the chicken embryo [5]. We
tested the potential of circulating yolk sac-derived cells
to differentiate into macrophages in vitro by culturing
whole blood from HH16 to HH17 embryos. In the
absence of growth factors, these circulating yolk
sac-derived cells failed to survive in culture, whereas
they rapidly differentiated into adherent cell mono-
layers in the presence of CSF1 (Figure 2A,B). The
resulting cells were identified as macrophages based on
their phagocytic capacity and expression of CSF1R,
MHCII and KUL01 (a chicken macrophage marker;
Figure 2C-G). Circulating yolk sac-derived cells were
found to have a high proliferative capacity, with mac-
rophages derived from 20 μl of whole blood expandingto approximately 90% confluence in a T80 flask after
21 days in culture.
To test the potential for circulating yolk sac-derived
cells to differentiate into macrophages in vivo we
injected blood from ubiquitously EGFP-expressing stage
HH16 to HH17 embryos into the dorsal aorta of age-
matched wild-type embryos. Donor-derived EGFP+ cells
were observed in the yolk sac in all embryonic stages
tested and in newly hatched chicks. Figure 3 shows rep-
resentative images of a number of locations in embryos
receiving transferred cells at different times of subse-
quent development. EGFP+ cells apparently (re)entered
the yolk sac compartment (Figure 3A). Figure 3B shows
the large number of EGFP+ cells infiltrating the eye, a
site of major embryonic macrophage infiltration detected
with the CSF1R-EGFP transgene previously [21], and also
observed in mouse Csf1r-EGFP transgenics [12]. As ex-
pected, and observed previously in the mouse [6,12],
EGFP+ cells were particularly concentrated in regions of
programmed cell death, such as the inter-digit region of
the limb buds (Figure 3C,D). Finally, consistent with the
reported ability of yolk sac-derived cells to give rise to
microglia [13,16,17], cells with the morphology of micro-
glia were still evident in the brain of all birds examined
at the time of hatch (Figure 3E). We confirmed the
phenotype of EGFP+ cells in recipient embryos by
confocal microscopy. EGFP+ cells were variable in
morphology, ranging from highly ramified cells in the
embryonic mesenchyme to rounded cells in the inter-
digit region of limb buds (Figure 4). All EGFP+ cells
were also labeled by immunohistochemistry with anti-
CSF1R, and rounded EGFP+ CSF1R+ cells in the inter-
digit region contained the condensed and fragmented
nuclei of apoptotic cells. Hence, the progeny of the
transplanted donor cells were functionally phagocytic
in vivo (Figure 4D-F).
To test the potential for circulating yolk sac-derived
cells to contribute to the adult macrophage pool, we
again injected blood from ubiquitously EGFP-expressing
stage HH16 to HH17 embryos into the dorsal aorta of
age-matched wild-type embryos. In three separate exper-
iments a total of 54 recipient embryos were injected; 29
chickens survived until sexual maturity (54% survival
rate at 16 weeks of age). In newly hatched chicks, occa-
sional highly ramified EGFP+ cells derived from the yolk
sac donors were still detectable in the brain. By contrast,
no evidence of EGFP fluorescence, compared with non-
transgenic birds, was detected in any tissue of any adult
bird including the brain when viewed as whole mounts
or in sections. As a positive control for effective transfer
in these hatched birds, EGFP+ cells were detected in the
testes of recipient males (Figure 3F), indicating the
presence of cells derived from donor primordial germ
cells that were co-transferred along with the yolk sac
DAPI Zymosan eGFPA B C
DAPI cIg eGFP DAPI CSF1R eGFP
DAPI MHCII eGFPDAPI KUL01 eGFP
D E
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Figure 2 Circulating yolk sac-derived cells from HH16 to HH17 stage embryos can be differentiated into macrophages in vitro. (A, B)
Twenty microliters of whole blood from five HH16 to HH17 stage embryos was cultured with (A) or without (B) 350 ng/ml chicken CSF1-Fc for
14 days. Note the confluent monolayer of cells in panel A, and the absence of any surviving cells in panel B. 20× magnification. (C) Shows the
ability of cells derived by cultivation from EGFP+ yolk sac donors to internalize fluorescent zymosan particles. (D, G) Shows the same cell
populations immunostained with control (D), anti-CSF1R (E) anti-KUL01 (F) or anti-MHCII (G). Scale bars = 10 μm.
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HH17 embryos [27].
To test the differentiation potential of definitive
hematopoietic cells under the same protocol, we injected
unfractionated bone marrow from newly hatched EGFP-
expressing chicks into the circulation of stage HH16 to
HH17 non-transgenic chicken embryos, before the ap-
pearance of the intra-aortic hematopoietic stem cell
clusters. The workflow for this experiment is shown in
Additional file 2: Figure S1. In each of three experi-
ments, 25 embryos were injected, and hatch rates varied
between 36% and 60%. As with the embryonic cell adop-
tive transfers, the injected embryos were examined for
the presence of EGFP-expressing cells of donor origin at
various stages of embryonic development, and some
were also taken to hatch. Tissues from these bone mar-
row chimeras were collected on hatch day, five 5 of age
and 6 weeks of age for similar examination.
Donor bone marrow-derived EGFP+ cells invaded the
whole embryo as shown in Figure 5A. The distribution
of EGFP-expressing cells in the host embryo was com-
parable to that observed in CSF1R-EGFP transgenic chick
embryos [21], including in the forming digits (Figure 5A;
panels iii and iv). The aggregation of macrophages toform primordia, detected with the CSF1R-EGFP or CSF1R-
mApple reporters, is the first sign of the future location
of organized lymphoid organs in the chick [21]. The
bone marrow donor-derived EGFP-expressing cells also
aggregated in lymphoid tissue primordia of the recipient
embryo (for example, the spleen in Figure 5A, panel vi).
The distribution of donor EGFP-expressing cells in
tissues was examined in post-hatch chimeras by whole
mount fluorescence imaging (Figure 5B). In contrast
with the loss of labeled cells in chicks injected with yolk
sac-derived cells, EGFP+ cells were so abundant through-
out all the tissues examined (that is, brain, skin, liver,
spleen, thymus, bursa, bone marrow and blood) that they
were easily detected in whole mounts. Furthermore, these
cells from the donor were still present in the tissues at
6 weeks of age, which was the latest time point examined.
They were particularly concentrated in the spleen and
bursa of Fabricius but less so in the liver, which is not a
major site of hematopoiesis during avian development
[28]. The donor-derived cells were also detected in the
brain and skin of all the chimeras generated. The presence
of EGFP-expressing cells in the thymus of the chimeras
implies that bone marrow donor-derived progenitors were




Figure 3 Embryonic yolk sac-derived cells give rise to macrophages in the embryo. Cells were isolated from the blood of EGFP+ embryos
at 3 days of development (HH16 to HH17), prior to the onset of definitive hematopoiesis (which occurs around HH17 to HH19 [26]), and injected
into the yolk sac circulation of age-matched non-transgenic recipients. The images are representative whole mounts at different times and
locations during subsequent development of separate individual birds. (A) Day 6 yolk sac blood vessels; note the extensive infiltration of the yolk
sac by the transferred cells. (B) Day 10 eye. (C) Day 7 inter-digit region. (D) Day 8 foot. (E) EGFP+ microglial cells in the brain of a chick on the
day of hatch. (F) Ubiquitous expression of EGFP in seminiferous tubules of a 16-week-old male recipient demonstrates successful establishment
of germ cell chimerism from donor primordial germ cells. In the same animal, there were no detectable EGFP cells in any other location viewed
as a whole mount. Scale bars A = 200 μm, B = 500 μm, C = 200 μm, D = 500 μm, E = 100 μm, F = 100 μm.
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thymus. The thymus ontogeny involves a cyclic succession
of receptive and non-receptive periods for stem cell entry
into the embryonic and early postnatal thymus [29]. To
confirm the identity of the bone marrow-derived donor
cells that persisted in the brains of the chimeras, coronal
sections of the right telencephalon were stained for ex-
pression of the leukocyte marker CD45 and for CSF1R.
All of the EGFP+ cells also expressed CD45 and CSF1R,
and had the characteristic ramified morphology of micro-
glial cells. Additional file 2: Figure S2 shows one example.
The EGFP+ macrophages in post-hatch chimeric birds
might derive from local self-renewal of macrophages
seeded during development, or from population of the
hematopoietic progenitor pools, or both [2,3]. We there-
fore examined whether injected EGFP+ bone marrow
cells isolated from newly hatched chicks could contrib-
ute to the progenitor pool in the marrow of recipients.
The bone marrow of 6-week-old chimeras contained10% to 20% of EGFP+ cells (Figure 6). The EGFP+ cells
were predominantly large and granular, and expressed
high levels of CD45, consistent with their identity as mac-
rophages (not shown). This restricted profile suggests that
the donor cells can only give rise to the macrophage
lineage in the recipient marrow. To confirm the contribu-
tion of the donor EGFP+ cells to macrophage progenitors,
chimeric marrow was cultured in presence of chicken
CSF1 for 7 days. A substantial proportion of the resulting
BMDM expressed EGFP. The positive cells occurred in
large clusters in the cultures, suggestive of colonies de-
rived from a progenitor (Figure 6).
The level of chimerism in spleens of recipient birds at
6 weeks of age was more difficult to assess. There was
an apparent increase in background fluorescence in the
chimeric birds. On flow cytometry, the entire fluores-
cence curve of large granular cells within the spleen was
shifted somewhat to the right, perhaps due to the uptake
of EGFP from dying cells (Additional file 2: Figure S3A).
A B C
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Figure 4 Cells derived from transferred yolk sac progenitors express surface CSF1R. Cells were isolated from the blood of EGFP+ embryos
at 3 days of development (HH16), prior to the onset of definitive hematopoiesis (which occurs around HH17 to HH19 [26]), and injected into the
yolk sac circulation of age-matched non-transgenic recipients. Embryos were incubated until stage HH33 (day 8 of development). The identity of
the EGFP+ cells derived from the donor transfer was confirmed by immunolocation of specific antigens. (A-C) Show different sections of embryonic
mesoderm from three separate recipients immunostained for CSF1R. Note that the all EGFP+ cells are also positive for surface CSF1R (yellow) and
exhibit a diverse range of morphologies. (D-F) Show sections of the limb bud inter-digit region immunostained for CSF1R. Note again that all
EGFP+ cells are also CSF1R+. In each case, the labeled cells contain numerous DAPI-stained fragments (arrow heads) indicative of the uptake of
apoptotic cells. Scale bars = 10 μm.
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spleens were stained using an antibody against the cell
surface antigen Bu-1, which is expressed on B cells and a
subset of macrophages [30]. None of the EGFP+ cells were
positive for Bu-1. The level of chimerism in the large
granular cell fraction was as high as 45% in two of
the birds examined in detail. Sustained chimerism was
confirmed in the bursa, where the background EGFP shift
was not observed (Additional file 2: Figure S3B). In this
organ, around 13% of the large granular cells were un-
equivocally EGFP+, whereas amongst small lymphocyte-
like fractions the proportion was only 1% to 2%. As in the
spleen, the EGFP+ cells in tissue sections did not stain for
Bu-1; indeed, the positive cells were excluded from the B
cell follicles. Conversely, all of the EGFP+ cells in both
spleen and bursa were stained with our recently described
antibody against CSF1R, and were not morphologically
distinct from the large pool of stellate interstitial CSF1R+
macrophages [20].
The responsiveness of embryonic macrophages to CSF1
The ability of donor bone marrow cells to proliferate
and differentiate when transplanted into the chick em-
bryo indicates that there is a macrophage-trophic envir-
onment. Consistent with this view, in situ hybridization
and quantitative RT-PCR demonstrated that both CSF1
and IL34 mRNA were highly expressed in the embryo,
especially in the head (and, in the case of IL34, the neuraltube) at the time of proliferation of the macrophage
populations expressing CSF1R mRNA (Additional file 2:
Figure S4A,B). To determine whether the availability of
CSF1R ligands is limiting for macrophage development,
we examined the effect of supplementing their availability
by direct microinjection. For this purpose, we developed a
chimeric chicken CSF1-Fc fusion protein (see Methods).
A similar construct for pig CSF1 was found to increase
the circulating half-life, because it increases the size of the
protein above the renal clearance threshold [31]. We
assayed the chicken CSF1-Fc using a chicken CSF1R-
expressing Ba/F3 line described previously [11] and found
that the addition of the Fc component did not alter
the relative activity (Additional file 2: Figure S5). The
MacGreen (CSF1R-EGFP) transgenic reporter chick em-
bryos [21] provided a convenient assay of the effect of
CSF1. The chicken CSF1-Fc conjugate was injected
into the neural tube of MacGreen embryos at HH21
and the number of CSF1R transgene-expressing cells
was evaluated 36 hours later. Definitive hematopoietic
stem cells appear in the aorta-gonad-mesonephros re-
gion at HH19 so the exogenous CSF1 injected at this
stage might act on both yolk sac and definitive mono-
cyte macrophages. There was no consistent difference
in the gross appearance or size of whole embryos
injected with chicken CSF1-Fc and PBS within the time
frame examined. However, when whole embryos were
viewed as whole mounts, there was a very obvious
AB
Figure 5 Bone marrow progenitors give rise to macrophages in the embryo and in adult birds. Bone marrow cells from newly hatched
EGFP+ donors were injected into the yolk sac circulation of HH16 non-transgenic recipients as described in Methods. (A) Images are representative
whole mounts taken under UV illumination at different times and locations during subsequent development, and in different recipients,
to provide an indication of the ability of the transplanted cells to populate all locations in the embryo: (i) whole embryo-E4; (ii) brain
cross-section-E5; (iii) hindlimb-E7; (iv) hindlimb digits-E10; (v) chorioallantoic membrane-E12; (vi) spleen-E13; (vii) femur cross section-E13; (viii)
intestine-E14. (B) Images are representative whole-mount images of the spleen, liver, bursa of Fabricius, thymus, brain and skin of representative
wild-type and EGFP-bone marrow chimeras at day 0, day 5 and 6 weeks of age as indicated. Scale bars = 200 μm.








Figure 6 Flow cytometry analysis of bone marrow chimeras. Bone marrow cells from EGFP+ donors were injected into the yolk sac
circulation of HH16 non-transgenic recipients as described in Methods. Dissociated bone marrow from 6-week-old chimeras was analyzed by
fluorescence-activated cell sorting. (A) A representative scatter plot of the cells; more complex than mammalian marrow because both red cells
and thrombocytes are nucleated. (B) A representative EGFP profile of control and EGFP-chimeric marrow. (C) Percentage chimerism across
multiple birds analyzed; the average is 13.72 ± 2.02% (corrected for the small number of autofluorescent cells in control marrow). (D) Bone
marrow cells from the newly hatched chimeric birds were cultivated in chicken CSF1 for 7 days to produce BMDM. In these cultures, large clusters
of EGFP+ cells, approximately consistent with the level of chimerism, were detected. Images are a representative cluster in which all of the cells
are EGFP+ (the apparent intensity varies within the cells in the cluster, depending upon how spread they are on the substratum).
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injected embryos were bright green (Additional file 2:
Figure S6A). The apparent increase in EGFP fluores-
cence was not focused at the site of injection, but was
manifest throughout the chicken CSF1-injected em-
bryos. Comparison of sagittal sections through the
body and of the footpad (Additional file 2: Figure S6B)
confirmed that the injected chicken CSF1-Fc did not
change the localization or distribution of EGFP+ cells,
and that the increased EGFP fluorescence was associ-
ated with an apparent increase in the numbers of
EGFP+ macrophages in the same locations.Control of macrophage production in newly hatched
birds by CSF1
Increased CSF1 can cause a large expansion of the
monocyte and tissue macrophage populations in mam-
mals, but this has never been studied in birds. We
therefore wished to determine whether the availability
of CSF1 remained limiting for the proliferation and dif-
ferentiation of macrophages in post-hatch life in the
chicken. For this purpose, the chicken CSF1-Fc was
injected into MacRed transgenic reporter chicken
hatchlings, in which CSF1R control elements drive
expression of mApple. There are limited alternative
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of the CSF1R reporter genes in chick was shown to be
coincident with CD45, surface CSF1R and staining
with lysotracker. Their location in regions of high cell
death and stellate morphology resemble the dis-
tribution of macrophages seen in mouse embryos. In
adult birds, all KUL01+ cells, including blood mono-
cytes and tissue macrophages also express the reporter
gene, but KUL01 is not a useful marker in the embryo
[21]. MacRed hatchlings were dosed subcutaneously
with 50 μg chicken CSF1-Fc or PBS on hatch day (day
0), day 1, day 2 and day 3, then sacrificed 24 hours after
the final injection.
CSF1 treatment caused a leukocytosis, with a two- to
three-fold increase in total white cell count in all treated
birds (not shown). The fluorescence-activated cell sort-
ing (FACS) profiles of the leukocytes are shown in
Figure 7A. The CSF1R-mApple transgene provides a
convenient marker for the monocytes. At first glance, it
appears that the proportion of monocytes in the blood
increased in response to chicken CSF1-Fc, but this is
actually entirely due to the proportional loss of throm-
bocytes. In the chicken, these cells are nucleated but
express relatively low levels of CD45 compared to other
leukocytes. As shown in Figure 7B, the ratio of
transgene-positive monocytes to CD45lo thrombocytes
was greatly increased by the chicken CSF1-Fc treatment.
Conversely, the leucocytosis was not selective for mono-
cytes. Indeed, the ratio of monocytes to B cells, T cells,
or total CD45hi cells was significantly reduced in the
treated birds. A similar pattern has been seen in mam-
mals, including primates, where CSF1 treatment caused
thrombocytopenia, but increased all the white cell popu-
lations [32].
As in the chicken CSF1-Fc-treated embryos described
above, whole mounts of tissues of the chicken CSF1-Fc-
treated birds could be distinguished from control based
upon expression of the CSF1R-mApple reporter gene. The
organs and tissues from the chicken CSF1-Fc-injected
chickens visibly glowed red by comparison to the con-
trols. Figure 8 shows en face views of skin and rectal
mucosa, and a whole mount view of the cecum showing
the cecal tonsil, of control and treated chicks. The view
of the rectum also highlights the remarkable concentra-
tion of CSF1R+ macrophages in the lamina propria, as
also seen in mice [12]. The conclusions based upon the
whole mount view were supported in every tissue exam-
ined by confocal fluorescence microscopy (that is,
spleen, bursa, liver, lung, kidney and muscle), where
there was an apparent increase in the number of
transgene-expressing cells. There also appeared to be an
increase in the brightness of expression in individual
cells (Additional file 2: Figure S7). In the spleen, the trans-
gene expression corresponds to the known macrophagedistribution in the white pulp, including inter-digitating
dendritic cells and ellipsoid-associated cells, and in the red
pulp [33]. Interestingly, the increase in fluorescent cells in
the bursa of newly hatched chicks dosed with chicken
CSF1-Fc was more striking in the macrophage population
lining the connective tissue between the B cell follicles
than in the population found in the medulla of the follicle,
called bursal secretory dendritic cells. In the liver, the
increased numbers of transgene-expressing Kupffer cells
in response to chicken CSF1-Fc were clustered around
sinusoids. A similar response was seen in the lung.
Transgene-expressing cells were scattered throughout
the interstitial tissue of the parabronchial wall in lung
from a PBS-treated chick, the increased numbers of
transgene-expressing cells in the chicken CSF1-Fc-treated
chicks were not associated with a major change in
distribution.
Despite the apparent changes in tissue macrophages in
the treated birds, there were no apparent adverse effects,
at least in the short time they were examined. The
treated and control groups gained weight at equal rates
(data not shown). CSF1 treatment in mice was reported
to cause splenomegaly and to promote liver and kidney
growth or repair [34,35]. By contrast, there was no effect
on any chicken organ weights in response to chicken
CSF1-Fc. As demonstrated in the defective bone resorp-
tion of the op/op mouse, CSF1 has a crucial role in
mammalian bone homeostasis through the differenti-
ation of osteoclasts, the bone resorbing cells [36].
Conversely, the increased numbers of osteomacs and
macrophages caused by the administration of CSF1 in a
mouse tibial bone injury model was associated with in-
creased matrix deposition and enhanced mineralization
[37,38]. The femur structure of the PBS- and chicken
CSF1-Fc-treated chicks was therefore analyzed by micro-
computed tomography. Rather unexpectedly, the treat-
ment increased bone formation. The bones of chicken
CSF1-Fc-treated chicks actually displayed a two-fold
higher bone volume to tissue volume than those of PBS-
treated hatchlings. Furthermore, the trabecular thickness
and the trabecular number were also increased in the
chicken CSF1-Fc-treated femurs (Figure 9).
Discussion
The yolk sac is believed to be the major source of pro-
genitors of many mouse tissue macrophage populations,
notably the microglia of the brain, based upon lineage
trace studies [39]. In the present study, we have ex-
tended the previous evidence that the developing
chicken contains an abundant macrophage population
that can be detected by localization of CSF1R mRNA or
novel CSF1R reporter genes [11,21]. The patterns of de-
velopment, migration and localization detected using a
CSF1R reporter were entirely consistent with previous
Figure 7 The effect of chicken CSF1-Fc on blood cell profiles in newly hatched birds. MacRed (CSF1R-mApple) birds were dosed subcutaneously
with 50 μg chicken CSF1-Fc or PBS on hatch day (day 0), day 1, day 2 and day 3, then sacrificed 24 hours after the final injection. Blood was collected
into heparinized tubes, and separated by density gradient centrifugation as described in Methods. The cells were stained with anti-CD45,
anti-CD3 or anti-BU-1, and analyzed by flow cytometry. (A) Representative FACS profiles of marker expression used to calculate the values in
(B). (B) Mean monocyte number (transgene-expressing cells) compared to mean thrombocyte number (CD45lo), mean leukocyte number
(CD45hi), mean thrombocyte + leukocyte number (CD45+), mean B cell number (BU-1+) or mean T cell number (CD3+) for each treatment
group. (C) Panels show representative FACS plots for the peripheral leukocyte populations from non-transgenic wild-type birds, or PBS or
chicken CSF1-Fc-treated MacRed birds as indicated, stained for CD45 (upper panels), Bu-1 (middle panels) or CD3 (lower panels). The
transgene (mApple) is on the y-axis, detecting the transgenic macrophages. PBS, treated with phosphate-buffered saline; WT, wild-type.
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Figure 9 The effect of chicken CSF1-Fc treatment on bone density. Ha
PBS on hatch day (day 0), day 1, day 2 and day 3, then sacrificed 24 hou
paraformaldehyde, and then transferred to 70% ethanol. Micro-compute
in Methods. Error bars represent standard error of the mean. Statistically
between treatment groups. PBS, phosphate-buffered saline.
Figure 8 The effect of chicken CSF1-Fc in macrophage
concentration in tissues detected by whole mount imaging of
MacRed chick. Hatchlings were dosed subcutaneously with 50 μg
chicken CSF1-Fc or PBS on hatch day (day 0), day 1, day 2 and day 3,
then sacrificed 24 hours after the final injection. Tissues were collected
quickly following the sacrifice of the chicks, and put in ice-cold PBS for
imaging under UV light using a red fluorescence filter for the same
exposure time. (A) Skin biopsy, 40× magnification. (B) Inner surface
of the rectum, split open, 80× magnification. (C) Cecum, 12.5×
magnification. PBS, phosphate-buffered saline.
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Our previous generation of recombinant chicken CSF1
[11] permitted the production of large numbers of pure
BMDM from chicken bone marrow. We compared their
gene expression to the total gene expression in the em-
bryo. The number of macrophages in the embryo was so
high that it was possible with deep-RNAseq analysis to
identify macrophage-expressed transcripts against the
background of the mRNA from numerous other cell
types. The chicken genome is still poorly assembled and
annotated, and large parts of the sequence (especially
some of the micro-chromosomes) are not even se-
quenced. Consequently, even after the de novo assem-
bly of the tags that did not originally map to the
genome, 10% of the new contigs were still not present
in the current assembly. These contigs could form the
basis of capture sequences to enable further refinement
of the genome sequence. The primary sequence data
have been provided to a consortium of avian re-
searchers, and used to refine annotation of the chicken
genome (Smith J, Burt D, et al., manuscript in prepar-
ation). As a first approximation, the data demonstrates
that tissue macrophages in a developing chick have a
similar transcriptome to CSF1-stimulated BMDM and,
by inference, CSF1R mRNA and the CSF1R reporter ex-
pression accurately locates macrophage-like cells. A
transcript annotated as the chemokine receptor CCR2 is
amongst the highly expressed genes shared by BMDM
and embryonic macrophages in the chick. This gene is
probably not a strict ortholog of mammalian Ccr2
([40], but the expression suggests a conserved function
with the mammalian receptor.tchlings were dosed subcutaneously with 50 μg chicken CSF1-Fc or
rs after the final injection. Femurs were fixed overnight in 4%
d tomography analysis of the femur was carried out as described
significant differences were calculated using unpaired t-tests
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study demonstrate that bone marrow progenitors
transplanted into a chick embryo before the onset of
definitive hematopoiesis can produce long-lived and
substantial chimerism restricted to the macrophage
compartment. This observation will be technically use-
ful for studies of the role of macrophages in innate im-
munity and the nature of immunological tolerance in
birds. For example, one might anticipate transplanting
marrow from birds that are resistance to a pathogen,
such as Salmonella [41] or Marek’s disease virus [42], to
determine whether resistance is macrophage-autonomous.
The effectiveness of chimera generation, even without
optimization, is especially surprising because we injected
unfractionated bone marrow. There is clearly the potential
to fractionate the marrow to identify CSF1R+ cells, and to
modify the recipient genetically to reduce the contribution
of endogenous hematopoietic progenitors to optimize this
technology. The finding indicates that the early embryonic
environment provides a niche that permits survival of clo-
nogenic macrophage progenitors that can return to the
marrow and repopulate the macrophage progenitor popu-
lation, to produce a new generation of macrophages in re-
sponse to CSF1. The same finding also indicates that the
bone marrow contains a population of committed pro-
genitor cells for the macrophage lineage that appear to be
distinct from the pluripotent stem cells. Pluripotent stem
cells did not apparently survive the embryonic envir-
onment available at the time of transfer, given that only
macrophages were of donor origin in the chimeras.
The macrophage progenitors that survive in the early
embryonic environment may be the equivalent of the
cells described recently in the mouse [43] or the high
proliferative-potential macrophage colony-stimulating
unit [44].
Yolk sac-derived blood cells that presented prior to
the onset of definitive hematopoiesis were capable of
extensive proliferation in response to chicken CSF1
ex vivo. When transplanted, they were apparently able to
populate the same macrophage populations in the em-
bryo as those derived from the bone marrow. But, unlike
bone marrow-derived cells, macrophages derived from
yolk sac donors were not retained into the adult bird
(Figure 3). Because neither the yolk sac cells, nor the
bone marrow cells, were pure populations, we cannot
eliminate the possibility that there was a quantitative
difference in the number of transferred precursor cells.
The recent literature from mouse systems, based on the
study of lineage trace and myb-knockout mice, has ac-
cepted that many yolk sac-derived macrophages persist
as a substantial distinct population in the adult [45]. By
contrast, a recent study by Epelman et al. [46] con-
cluded that liver, heart and brain were the only mouse
organs in which yolk sac-derived macrophages persistinto adulthood in significant numbers, and even then
they were a minor subpopulation. As discussed else-
where [2,3], our interpretation of the data in mouse and
the current data for the chick is that yolk sac-derived
and definitive macrophages can occupy the same specific
niches and in normal development the cells derived
from the yolk sac are replaced by fetal liver or bone mar-
row monocyte-derived cells.
We have shown that CSF1 and IL34 are expressed
during chicken embryonic development. By injecting a
novel form of recombinant CSF1, chicken CSF1-Fc, into
both the developing embryo and the hatchling bird, we
have shown that CSF1R signaling is limiting for the
proliferation and differentiation of tissue macrophages in
birds as it is in mammals. Inter alia, these observations
further highlight the utility of the MacGreen and
MacRed reporter genes in the chick to monitor alter-
ations in mononuclear phagocyte number, location and
behavior [21]. One unexpected effect of chicken CSF1-
Fc in hatchlings was the increase in lymphocytes as well
as monocytes, since these cells do not express CSF1R.
This could arise because of the remarkable concentra-
tion of CSF1R-expressing cells in white pulp of spleen,
and in the bursa. This is not the case in mammals,
where macrophages are largely confined to red pulp and
marginal zones. It may be that the CSF1-stimulated
macrophages produce factors that promote lymphocyte
proliferation or migration. Alternatively, in the mouse,
pigCSF1-Fc treatment greatly increased tissue macrophage
numbers, through both local proliferation and monocyte
extravasation [47]. So, in the treated chicks, the chicken
CSF1-Fc could act in at least two ways, by promoting
proliferation of precursors and tissue macrophages, and
by driving the monocytes selectively to leave the
circulation.
Conclusion
Data we have presented here support the use of the
chick model in the study of monocytopoiesis, and dem-
onstrate that CSF1R transgenic reporters will enable the




Antibodies and dilutions used were as follows: chicken CD3
(clone CT3, Southern Biotech, Birmingham, Alabama, USA),
1:100 for FACS; Bu-1 (clone AV20, Southern Biotech),
1:1,000 for FACS, 1:300 for immunofluorescence; CD45
(clone AV53), 1:1,000 for FACS and immunofluorescence;
chicken CSF1R [20], 1:100 for immunofluorescence; GFP
Rabbit IgG Antibody Fraction, Alexa Fluor 488 Conjugate
(Invitrogen, Carlsbad, CA, USA), 1:500 for immunofluor-
escence; Goat-anti-mouse-IgG1-alexa 647 (Invitrogen),
Garceau et al. BMC Biology  (2015) 13:12 Page 13 of 171:5,000 for FACS; Alexa Fluor 546 F(ab')2 Fragment of Goat
Anti-Mouse IgG (Invitrogen), 1:500 for immunofluorescence.
Cells and animals
DF-1 cells were originally obtained from the American Type
Culture Collection (ATCC, UK), and grown in Dulbecco’s
modified minimal essential medium (DMEM) supplemented
with 100 μg/ml penicillin and 100 μg/ml streptomycin (P/S),
10% FBS (PAA/GE Healthcare Life Sciences, UK) and 2%
chick serum (Sigma-Aldrich, UK) by volume at 39°C.
CHO cells were originally obtained from ATCC, and
grown in Hams-F12 media (Life Technologies, UK) supple-
mented with 10% FBS, non-essential amino acids and
sodium pyruvate at 37°C in 5% CO2.
Ba/F3 cells expressing the chicken CSF1R were de-
scribed previously [11], and were used in the generation
and characterization of monoclonal antibodies against
the chicken CSF1R [20], also used herein. They were
maintained in RPMI-1640 medium (Sigma-Aldrich) sup-
plemented with 10% heat-inactivated FBS, 2 mM L-glu-
tamine and antibiotics (100 g/ml penicillin, 100 g/ml
streptomycin) and 10% conditioned medium from X63
Ag8-653 myeloma cells carrying an expression vector for
IL-3 [48] at 37°C.
Chicken bone marrow cells were obtained from day-
old chicks by flushing the marrow from femurs and
tibias with PBS using a syringe and a blunt needle. The
marrow from multiple bones was pooled and washed
once in RPMI-1640, passed through a 100 μm cell
strainer (Falcon), and resuspended in a small volume
(150 μl per bone) for micro-injection. BMDM were pro-
duced by adapting methods previously employed for
mouse and pig cells in our laboratory [49]. Briefly, mar-
row cells were harvested from femurs of hatchling birds,
resuspended in RPMI supplemented with 10% heat-
inactivated FCS, 2 mM L-glutamine, 100 μg/ml penicil-
lin, 100 μg/ml streptomycin, and 125 ng/ml recombinant
chicken CSF1 ([11] and plated in 60 mm bacteriological
plates (Sterilin) at a density equivalent to one bone per
plate. Cells were then incubated at 37°C in a CO2 incu-
bator for 7 days.
Chicken circulating yolk sac-derived cells were
obtained by extracting blood from the dorsal aorta of
stage HH16 to HH17 embryos with ubiquitous EGFP
expression using a fine glass micropipette under a
stereomicroscope. Blood from five embryos was pooled
and 20 μl of whole blood added to 2 ml of medium in
six-well Corning Costar cell culture plates. Medium
was composed of DMEM High glucose - GlutaMAX
(Life Technologies), supplemented with 10% heat-
inactivated FCS, 10% Gibco MEM Non-Essential Amino
Acids, 100 μg/ml penicillin, 100 μg/ml streptomycin, and
in some cases 350 ng/ml recombinant chicken CSF1 at
37°C.For zymosan phagocytosis and confocal analysis after
10 days in culture with CSF1, macrophages were trans-
ferred into four-well Nunc Lab-Tek Chamber Slides
and cultured for a further 48 hours. In some cases,
100 μg/ml of Texas Red-conjugated zymosan BioParti-
cles (Life Technologies) was added to cells for one
hour, then washed four times and fresh medium was
added to cells for 24 hours. Cells were fixed for 30 minutes
at room temperature with 4% PFA/PBS and washed
three times with PBS. Cells were stained as described
below.
Wild-type ISA Brown layer birds, and constitutive
EGFP-expressing birds derived from the same genetic
background [18] were obtained from the National Avian
Research Facility at The Roslin Institute, Edinburgh.
Transgenic birds expressing either mApple or EGFP
driven by promoter and enhancer elements of the
chicken CSF1R locus are described in detail elsewhere
[21]. These birds were also maintained at the National
Avian Research Facility. Young chick embryos were
staged in accordance with Hamilton and Hamburger’s
tables [50]. The ages of more advanced embryos and
hatched chicks are indicated by the incubation or post-
hatching day.
RNAseq
RNA from chicken BMDM (produced as described
above), day 7 embryos or DF-1 cells was extracted using
TRIzol reagent, as described by the manufacturers (Invi-
trogen). RNA was quantified using a Nanodrop and
RNA quality was assessed using an Agilent Nano Chip
kit. Sequencing was performed by Ark Genomics (Roslin
Institute) using the Illumina HiSeq 2000 Sequencing
System. Short reads were filtered for quality, and mapped
to the annotated chicken genome using TopHat. Read
counts production, normalization of data, gene annotation
and de novo assembly of the unmapped reads were per-
formed by Edinburgh Genomics staff within The Roslin
Institute. Enriched candidate genes were determined by
calculating the ratio of the read counts between chicken
BMDM and DF-1, embryos and DF-1, or chicken BMDM
and embryos. RNAseq data have been lodged with Array
Express (E-MTAB-3048) and contributed to the chicken
RNAseq Consortium.
In situ hybridization
Fertilized White Leghorn eggs were collected weekly
and incubated at 38°C for between 3 and 6 days of devel-
opment. Embryos were dissected into cold DEPC-PBS,
staged as above, fixed immediately in 4% PFA with
DEPC-PBS overnight, dehydrated into 100% methanol
through gradual methanol and PBS steps, and stored
at -20°C. The CSF1R and IL34 probes were made
using cDNA clones 654 and 591, respectively, obtained
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ics, Roslin, UK) as the template. Whole-mount in situ
hybridization on embryos was carried out as described [51].
Chicken CSF1-Fc production
We have described elsewhere the production of fusion
protein between pig CSF1 and the Fc fragment of im-
munoglobulin [31]. To produce a similar form of chicken
CSF1, we fused the coding sequence of the minimal active





FEKDCSQVYRSACAGPRQHSSSP) with a linker (GGG







QKQAGK) and a histidine tag (HHHHHH). The entire
amino acid sequence was reverse-translated and codon-
optimized for expression Chinese Hamster Ovary (CHO)
and synthesized by Blue Heron Biotechnologies (WA,
USA). The sequence was engineered with a HindIII
restriction site and Kozak sequence (GCCACC) at the
5′ end, and a stop codon and EcoRI restriction site at
the 3′ end, and cloned into the expression plasmid
pCDNA3.1(+) (Invitrogen) using the complementary
restriction sites. The resulting plasmid was subse-
quently used as the source of DNA for subcloning into
a stable cell expression system.
One day before transfection, 5 × 106 cells CHO cells
were seeded in 6 ml growth medium without antibiotics
in a T25 flask, and 24 hours later were transfected with
10 μg cCSF1R-Ig + pFUSE-IgG1-Fc DNA using Lipofec-
tamine 2000 (Life Technologies), following manufac-
turer’s instructions. The following day, the transfection
medium was replaced with growth medium supplemented
with 250 μg/ml Zeocin (InvivoGen, Toulouse, France) to
select for Zeocin-resistant transfectants. After 3 weeks of
growth in selective medium, foci of Zeocin-resistant stable
transfectants were screened, cloned and expanded.
The Fc fusion protein was isolated using a combin-
ation of mixed modal and immobilized metal ion affinity
chromatography steps. Conditioned medium from the
transfected CHO cell culture was clarified and sodium
citrate was added to a 50 mM final concentration. The
pH of the conditioned medium was adjusted to 5.5 and
the medium was clarified by filtration. Chromatography
was performed on Capto MMC. The GE was as follows:
the resin was equilibrated with 50 mM sodium citratepH 5.5 (A1), the medium was loaded and the column
was washed with A1 until the A280 returned to baseline.
The resin was washed with 50 mM sodium citrate
pH 5.5, 0.7 M NaCl (A2) and a gradient to 50 mM Tris
pH 8.5; 0.5 M NaCl was used to elute the fusion
protein-rich fraction. Affinity chromatography was ac-
complished using Ni-NTA resin, equilibrated with A
buffer (50 mM Tris pH 8, 300 mM NaCl). The Capto
MMC-rich pool was batch-bound to resin for 60 minutes
and elution of the desired protein was performed with
an imidazole gradient. Protein-rich fractions were pooled
based on SDS-PAGE and dialyzed into PBS.Cell transplantation and embryo culture
Blood was extracted from the dorsal aorta of stage
HH16 to HH17 embryos with ubiquitous EGFP expres-
sion using a fine glass micropipette under a stereomicro-
scope. Approximately 5 to 7 μl of blood was collected
per embryo and the blood from 10 embryos was pooled.
Bone marrow cells from day-old chicks were extracted
as described above. Yolk sac hematopoietic or bone mar-
row cell chimeras were made by microinjecting a 3 to
5 μl aliquot of EGFP+ blood or bone marrow into the
dorsal aorta of aged-matched non-transgenic recipient
embryos. Recipient embryos were monitored throughout
embryonic development to assess transplantation of
EGFP+ cells. To generate adult yolk sac hematopoietic
or bone marrow chimeras, embryos were transferred
into phase III host shells and cultured to hatching as de-
scribed [18].Flow cytometric analysis
Heparinized blood was diluted with PBS to about 3 ml
and layered on top of 3 ml Histopaque 1.077 in a 15 ml
Falcon tube, and cells isolated by centrifugation at 400 × g
for 20 min and both acceleration and deceleration set at 1.
Cells at the interface were washed three times with PBS,
spun at 350 × g for 5 minutes at 4°C, and resuspended in
0.5 ml FACS buffer (PBS supplemented with 0.5% BSA
and 0.05% NaN3). Tissues were collected in ice-cold PBS,
finely chopped with microscissors and passed through
100 μm cell strainers (Falcon). Chicken bone marrow cells
were washed three times with PBS (350 × g for 5 minutes
at 4°C), passed through a 100 μm cell strainer, and 106
cells added per well in a U-shaped 96-well plate. Cells
were stained sequentially with primary and secondary
antibody, washed three times in buffer between incuba-
tions by centrifugation for 3 minutes at 350 × g and 4°C.
Cells were resuspended in FACS buffer (100 μl/well), and
transferred to FACS tubes filled with 200 μl FACS buffer.
Analysis was performed on a FACScalibur flowcytometer
(BD Biosciences, UK). Data were analyzed using the soft-
ware program Summit v4.3 (Dako, UK).
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mount fluorescence imaging
MacGreen fertile eggs were incubated at 38°C for
4.5 days prior to injection. Micro-capillary tubes
(Harvard Apparatus, UK) with a 1.5 mm external and
1.17 mm internal diameter were made into glass nee-
dles using a moving-coil microelectrode puller, model
753 (Campden Instruments Ltd, UK). Sharp scissors
were used to make a hole in the shell of an egg at the
blunt end. The embryo was visualized by cutting a
window in the eggshell. Chicken CSF1-Fc conjugate
was taken up into a glass capillary and injected in the
neural tube of the host embryos. Control embryos
were injected with PBS vehicle. Windowed eggs were
resealed with tape and returned to the incubator for
36 hours. Embryos were removed from the egg, placed in
PBS, and whole mount imaging performed using a Leica
MZFLIII fluorescent microscope.
Embryo fixation and confocal fluorescence imaging
Embryos were fixed for 1 hour in 4% paraformaldehyde
in PBS, washed in PBS and incubated overnight in 18%
sucrose in PBS. Embryos were then cryo-embedded in
Tissue-Tek OCT compound (Sakura Finetechnical,
Tokyo, Japan) and sectioned at 10 μm onto SuperFrost
Plus slides (Menzel-Gläser, Germany). Sections were left
to dry, and visualized using an inverted confocal micro-
scope (Nikon eC1; Nikon Instruments). Images were
captured using Nikon EZ- C1 Software v3.40. Lymphoid
tissues in embryonic and post-hatch birds were imaged
by dissecting the relevant organ, which was placed in a
petri-dish for whole mount imaging using a Leica
MZFLIII fluorescent microscope. Tissues were fixed and
embedded as above. Sections were left to dry, then
blocked for 1 hour in 10% skim milk powder, 10% nor-
mal horse sera and 0.1% Triton X-100 in PBS (MST-
PBS). Primary antibodies were added (anti-CSF1R, anti-
CD45, anti-Bu-1), diluted in MST-PBS and sections in-
cubated at 4°C overnight. Sections then were washed for
30 minutes in PBS and re-incubated with secondary
antibody (Alexa Fluor 546 F(ab')2 Fragment of Goat
Anti-Mouse IgG (Invitrogen) and anti-GFP Rabbit IgG
Antibody Fraction, Alexa Fluor® 488 Conjugate (Invitro-
gen)) diluted in MST-PBS for one hour. Sections were
washed for 30 minutes in PBS, and mounted in Hydro-
mount (National Diagnostics, Atlanta, Georgia, USA). Cells
were imaged using an inverted confocal microscope (Nikon
eC1; Nikon Instruments).
Subcutaneous injection of chicken CSF1-Fc in hatchlings
Freshly hatched MacRed chicks were weighed and divided
into treatment groups that were matched for body weight.
Six MacRed and two wild-type chicks were sacrificed prior
to the course of injection for baseline level assessment.Subcutaneous injections were performed at the same time
daily, at two different sites in the upper body with 1 mg/
kg (50 μg chicken CSF1- Fc/chick in PBS) for four treat-
ments (day 0 to day 3). Control birds were injected with
PBS. Birds were weighed daily, prior to injection, and on
the day of sacrifice (day 4). Chicks were sacrificed 24 hours
post-last injection. Blood was collected using heparinized
syringes and needles. Whole mount tissues were imaged
under UV light using a red fluorescence filter for the same
exposure time. All tissues were then fixed in 4% PFA for
4 hours followed by overnight incubation at 4°C in 18%
sucrose, except one lobe of each liver, one piece of muscle
of every chick, and every other small intestine
(whole), which were put in RNAlater (QIAGEN) and
stored at -80°C. Tibias were kept in cold PBS until
bone marrow extraction for FACS analysis of trans-
gene expression. Femurs were fixed in 4% PFA, and
sent for micro computed tomography using a Skyscan
1172 scanner (Skyscan, Kontich, Belgium) and sectioning.
PFA-fixed tissues were cryo-embedded in Tissue-Tek
OCT compound (Sakura Finetechnical) and sectioned
at 10 μm onto SuperFrost Plus slides (Menzel-Gläser).
Sections were left to dry and visualized using an
inverted confocal microscope (Nikon eC1; Nikon
Instruments). Images were captured using Nikon EZ-C1
Software v3.40.
Additional files
Additional file 1: Table S1. Transcription factors known to be
involved in myeloid lineage-specific hematopoiesis. Table S2. Known
macrophage-expressed genes that were detected at comparable levels to
CSF1R in total embryo mRNA. Table S3. Genes with enriched expression
in chicken BMDM relative to fibroblasts but not in embryonic
macrophages.
Additional file 2: Figure S1. Generation of bone marrow chimeras.
Figure S2. EGFP-expressing cells in the brain parenchyma of chimeras.
(A) Co-localization of EGFP and CSF1R. (B) Co-localization of EGFP and
CD45. Scale bars = 500 μM. Figure S3A. Characterization of chimeric
spleen. (A) Representative FACS plot. (B) Representative fluorescence profiles
for large granular EGFP+ cells in control. (C) Chimerism depends upon
gates, conservative suggests 45% (green), and relaxed (blue) suggests 55%.
(D) Chimerism in three birds, based upon conservative gating. (E) No
co-expression of EGFP and B cell marker Bu-1 (red) (upper panel).
Co-expression of EGFP and CSF1R (red) (lower panel). Figure S3B.
Characterization of chimeric bursa of Fabricius. (A) Representative FACS plot.
Cell populations were divided according to size and granularity, and
number of EGFP+ cells determined. (B) No co-expression of EGFP and
Bu-1 (red) (left panel). Co-expression of EGFP and CSF1R (red) (right panel).
Scale bars = 100 μM. Figure S4. (A) Localization of IL34 mRNA by whole
mount in situ. Sense control probe (left). Antisense probe (right). Upper
panel: Arrows indicate regions of stronger expression. Lower panel: The
head. Arrow indicates the notochord. (B) Expression in the embryo’s head
by quantitative RT-PCR. Figure S5. Relative bioactivity of chicken CSF1 and
chicken CSF1-Fc on chicken CSF1R-expressing Ba/F3.
Figure S6. Fertile MacGreen eggs injected with PBS (left) or chicken
CSF1-Fc (right). (A) Upper panels were under visible light (12.5×), lower
panels show hindlimbs (hl) under UV light using a GFP filter (40×). (B) Upper
panels show 10 μm sagittal section through the somites. Lower panels
show the hindlimb. Scale bars = 200 μM. Figure S7. Transgene-expressing
cells in tissues from MacRed chicks treated with chicken CSF1-Fc. Spleen (i);
Garceau et al. BMC Biology  (2015) 13:12 Page 16 of 17bursa of Fabricius (ii); liver (iii); lung (iv); kidney (v); brain (vi); muscle, cross
(vii); muscle, longitudinal (viii). Scale bars: A,B,E,F,G,H = 50 μM; C = 25 μM;
D = 100 μM.
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